Table 1.
Parameter | n = 43 |
---|---|
Age (years) (mean ± SD) | 50 ± 15 |
Male n (%) | 15 (34.8) |
Female n (%) | 28 (65.2) |
Age of onset (years) (mean ± SD) | 21 ± 20 |
Duration of disease (years) (mean ± SD) | 31 ± 19 |
BMI (kg/m2) (mean ± SD) | 26.2 ± 5.6 |
Essential symptoms n (%) | 37 (86.0) |
Snoring | 30 (69.8) |
Excessive daytime sleepiness | 32 (74.4) |
Witnessed apnea | 11 (25.6) |
Sputum colonization n (%) | 16 (37.2) |
Pseudomonas aeruginosa | 10 (23.0) |
Candida albicans | 1 (2.0) |
Escherichia coli | 1 (2.0) |
Haemophlius influenzae | 2 (5.0) |
Pseudomonas alcaligenes | 1 (2.0) |
Klebsiella | 1 (2.0) |
Brochiectasis localization n (%) | |
Right upper lobe | 17 (39.0) |
Right middle lobe | 19 (44.0) |
Right lower lobe | 24 (56.0) |
Left upper lobe | 12 (27.0) |
Lingula | 20 (46.0) |
Left lower lobe | 27 (62.0) |
Type of bronchiectasis n (%) | |
Cystic | 12 (28.0) |
Cylindrical | 17 (40.0) |
Varicose | 7 (16.0) |
Traction | 5 (12.0) |
Number of lobes with bronchiectasis n (mean ± SD) | 2.3 ± 1.6 |
Spirometry | |
FVC (%) (mean ± SD) | 78.9 ± 20.0 |
FEV1 (%) (mean ± SD) | 64.5 ± 24.1 |
FEV1/FVC (%) (mean ± SD) | 66.7 ± 13.9 |
FEV1/FVC<%75 n (%) | 29 (67.4) |
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SD, standard deviation.